Cargando…

Pharmaceutical use according to participation in worksite wellness screening and health campaigns

This study evaluated whether participation in worksite wellness screening and health campaigns influences the number and cost (USD) of pharmacy medication claims. Analyses are based on 2531 workers employed all four academic years in a large school district in the western United States, 2010–11 thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Merrill, Ray M., Telford, Carson T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156915/
https://www.ncbi.nlm.nih.gov/pubmed/30263886
http://dx.doi.org/10.1016/j.pmedr.2018.09.008
_version_ 1783358181835014144
author Merrill, Ray M.
Telford, Carson T.
author_facet Merrill, Ray M.
Telford, Carson T.
author_sort Merrill, Ray M.
collection PubMed
description This study evaluated whether participation in worksite wellness screening and health campaigns influences the number and cost (USD) of pharmacy medication claims. Analyses are based on 2531 workers employed all four academic years in a large school district in the western United States, 2010–11 through 2013–14. Mean and ratio comparisons were adjusted by age, sex, year, and baseline health. Approximately 84.2% of employees participated in wellness screening and 60.1% completed one or more health campaigns. Those completing wellness screening were 1.09 (95% CI 1.06–1.13) times more likely to file a claim. Mean total cost remained near $934 (SD = $3695) over the academic years, positively associated with years of wellness screening, suggesting increased awareness of the need for medication through screening. Women were 1.02 (95% CI 1.00–1.05) times more likely than men to participate in wellness screening and had greater total pharmacy cost ($990.6 [SD = $4023.7] vs. $777.9 [SD = $2580.5], p = 0.0104). Women were 1.38 (95% CI 1.32–1.44) times more likely to complete a health campaign. Mean number of pharmacy claims was lower (9.8 vs. 10.6, p = 0.0069) in those completing at least one health campaign, suggesting greater health orientation in women. Those completing at least one health campaign were 0.96 (95% CI 0.92–0.99) times as likely to have a total cost of medication above the median, 0.94 (95% CI 0.88–1.01) as likely to have a total cost of medication above the 75th percentile, and 0.84 (0.75–0.96) times as likely to have a total cost above the 90th percentile.
format Online
Article
Text
id pubmed-6156915
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61569152018-09-27 Pharmaceutical use according to participation in worksite wellness screening and health campaigns Merrill, Ray M. Telford, Carson T. Prev Med Rep Regular Article This study evaluated whether participation in worksite wellness screening and health campaigns influences the number and cost (USD) of pharmacy medication claims. Analyses are based on 2531 workers employed all four academic years in a large school district in the western United States, 2010–11 through 2013–14. Mean and ratio comparisons were adjusted by age, sex, year, and baseline health. Approximately 84.2% of employees participated in wellness screening and 60.1% completed one or more health campaigns. Those completing wellness screening were 1.09 (95% CI 1.06–1.13) times more likely to file a claim. Mean total cost remained near $934 (SD = $3695) over the academic years, positively associated with years of wellness screening, suggesting increased awareness of the need for medication through screening. Women were 1.02 (95% CI 1.00–1.05) times more likely than men to participate in wellness screening and had greater total pharmacy cost ($990.6 [SD = $4023.7] vs. $777.9 [SD = $2580.5], p = 0.0104). Women were 1.38 (95% CI 1.32–1.44) times more likely to complete a health campaign. Mean number of pharmacy claims was lower (9.8 vs. 10.6, p = 0.0069) in those completing at least one health campaign, suggesting greater health orientation in women. Those completing at least one health campaign were 0.96 (95% CI 0.92–0.99) times as likely to have a total cost of medication above the median, 0.94 (95% CI 0.88–1.01) as likely to have a total cost of medication above the 75th percentile, and 0.84 (0.75–0.96) times as likely to have a total cost above the 90th percentile. Elsevier 2018-09-11 /pmc/articles/PMC6156915/ /pubmed/30263886 http://dx.doi.org/10.1016/j.pmedr.2018.09.008 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Merrill, Ray M.
Telford, Carson T.
Pharmaceutical use according to participation in worksite wellness screening and health campaigns
title Pharmaceutical use according to participation in worksite wellness screening and health campaigns
title_full Pharmaceutical use according to participation in worksite wellness screening and health campaigns
title_fullStr Pharmaceutical use according to participation in worksite wellness screening and health campaigns
title_full_unstemmed Pharmaceutical use according to participation in worksite wellness screening and health campaigns
title_short Pharmaceutical use according to participation in worksite wellness screening and health campaigns
title_sort pharmaceutical use according to participation in worksite wellness screening and health campaigns
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156915/
https://www.ncbi.nlm.nih.gov/pubmed/30263886
http://dx.doi.org/10.1016/j.pmedr.2018.09.008
work_keys_str_mv AT merrillraym pharmaceuticaluseaccordingtoparticipationinworksitewellnessscreeningandhealthcampaigns
AT telfordcarsont pharmaceuticaluseaccordingtoparticipationinworksitewellnessscreeningandhealthcampaigns